Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse

IntroductionTo sustain the achievement of kala-azar elimination program (KEP), early detection and treatment of the visceral leishmaniasis (VL) cases and associated modalities such as treatment failure (TF), relapse VL (RVL), and Post-kala-azar dermal leishmaniasis (PKDL) is the cornerstone. A predi...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Dinesh Mondal, Prakash Ghosh, Rajashree Chowdhury, Christine Halleux, Jose A. Ruiz-Postigo, Abdul Alim, Faria Hossain, Md Anik Ashfaq Khan, Rupen Nath, Malcolm S. Duthie, Axel Kroeger, Greg Matlashewski, Daniel Argaw, Piero Olliaro
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2019-10-01
Reeks:	Frontiers in Microbiology
Onderwerpen:	visceral leishmaniasis (VL) treatment failure (TF) relapse VL (RVL) Post-kala-azar dermal leishmaniasis (PKDL) rK39 antibody ELISA
Online toegang:	https://www.frontiersin.org/article/10.3389/fmicb.2019.02268/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!